Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Genetic Engineering News: Breaking Genetic Engineering News, Comments and Articles.

09:57 EDT 23rd July 2014 | BioPortfolio

Genetic Engineering NewsRSS

Read the latest Genetic Engineering News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Genetic Engineering.

Search or Follow Our Genetic Engineering News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Genetic Engineering News.

Showing "genetic engineering genetics" News Articles 1 to 25 of 7,700+

Wednesday 23rd July 2014

New Clinical Study Aims to Investigate the Genomics of Young Lung Cancer

Addario Lung Cancer Medical Institute Puts Spotlight on Lung Cancer in Young Adults The Addario Lung Cancer Medical Institute (ALCMI) today launched a new study, the Genomics of Young Lung Cancer, to understand why lung cancer occurs in young adults, who quite often are athletic, never smokers and do not exhibit any of the known lung cancer genetic mut...

The Personalized Medicine Initiative and Contextual Genomics Announce a National Access Project for Cancer Testing

The Personalized Medicine Initiative (PMI) and Contextual Genomics have partnered to launch a National Access Project for Cancer Testing. The project is designed to change clinical practice by allowing medication selection on the basis of an individual’s genetic tumor profile. The testing is for actionable mutations and designed to improve clinical outco...

MedicationDiscountCard.com Makes Tazorac Discount Cards For Psoriasis Sufferers

MedicationDiscountCard.com aims to help those suffering from psoriasis afford needed prescriptions. Margate City, NJ (PRWEB) July 23, 2014 Psoriasis is an autoimmune disease that is most often associated with dry, red patches on the skin—but this disease is not just skin deep. It can increase a victim’s risk for cardiovascular disease, some cancers, certain types of arthritis, or ulcerative c...

TicTocStop.org is Improving the Lives of Kids with Tourette Syndrome by Lessening the Tics Associated with the Disorder; Help Them Do It During "A September to Remember"

CBS Sports Personality Craig Carton's TicTocStop Foundation is helping to improve the lives of kids with Tourettes by decreasing the Tics Associated with the neurological disorder. New York, New York (PRWEB) July 23, 2014 “A SEPTEMBER TO REMEMBER” September 1st, 2014 begins TicToc Awareness Month. The foundation is closer than ever and working feverishly in finding ways to improve the liv...

Surge in R&D Investments to Drive the Global Biocompatible Materials Market, According to New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on Biocompatible Materials markets. Global market for Biocompatible Materials is projected to reach US$106.7 billion by 2020, driven by emerging new applications and technology breakthroughs in biomaterial science. San Jose, California (PRWEB) July 23, 2014 Follow us on LinkedIn – Biocompatible materials are biodegradable substances exc...

Fibrocell Science Takes Active Role to Support Dystrophic Epidermolysis Bullosa Patient Advocacy Group

Company to Address Potential of Genetically-Modified Autologous Fibroblasts for RDEB at 2014 DebRA Patient Care Conference Fibrocell Science, Inc., (NYSE MKT:FCSC), an autologous cell therapy company primarily focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, announce...

bioTheranostics Names Ramesh Hariharan as Vice President of Marketing

bioTheranostics, Inc., the leading genomic solutions provider for cancer diagnosis, today announced the addition of Ramesh Hariharan, Ph.D., to the company’s senior management team as vice president of marketing. Hariharan will lead bioTheranostics’ commercial development and marketing efforts for the company’s suite of

Gen9 Launches New Product to Enable Pathway and Genome Building

With the capacity to produce extremely long DNA constructs, Gen9 continues to push the boundaries of synthetic biology innovation while expanding its solutions for customers Gen9, Inc., the pioneer in the development of scalable technologies for synthesizing and assembling DNA, today announced the commercial launch of GeneByte Plus™ DNA con...

DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology

Gutterson joins Pioneer from Mendel Biotechnology DES MOINES, Iowa (PRWEB) July 23, 2014 DuPont Pioneer announced today that Neal Gutterson, Ph.D., will join the business as vice president of Agricultural Biotechnology (ABT), effective July 21, 2014. Gutterson joins Pioneer from Mendel Biotechnology where he served most recently as president, chief executive officer and board member. “Neal brin...

Eagle Pharma's drug to treat genetic condition gets U.S. approval

July 23 (Reuters) - Eagle Pharmaceuticals Inc said the U.S. Food and Drug Administration approved its drug to treat an inherited life-threatening condition called malignant hyperthermia (MH).

Synlogic raises $29.4 million in series A financing

Synlogic announced the company raised $29.4 million in a Series A financing led by Atlas Venture and New Enterprise Associates. Synlogic plans to use the proceeds from this financing to further develop its first-in-class proprietary microbial engineering platform for the development of therapeutic microbes and advance its preclinical pipeline across several clinical applications. Their tools, more...

Thermo Fisher profit tops Street with Life Tech contribution

July 23 (Reuters) - Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, reported a higher-than-expected second-quarter profit in its first full quarterly results to include its acquisition of genetic testing company Lif...

Praxair Declares Dividend in Third Quarter 2014

The board of directors of Praxair, Inc. (NYSE:PX) has declared a quarterly dividend of 65 cents per share, unchanged from the previous quarter. The dividend is payable on September 15, 2014, to shareholders of record on September 8, 2014. About Praxair Praxair, Inc., a Fortune 250 company with 2013 sales of $12 billion, is the larg...

EH&E and Brigham and Women's Hospital Win IFMA Excellence Award for Advancing Fire, Life Safety in Construction Practices

NEEDHAM, Mass., July 23, 2014 /PRNewswire/ -- EH&E, a leading provider of environmental and engineering consulting services, has won the 2014 IFMA Boston Excellence Award for Best Practices in Sustainability for a joint project conducted with Brigham and Women's Hospital (BWH). The award honors a new approach — commissioned by BWH and designed by EH&E — that "sets a new be...

Tulane University psychiatrist to study how parental bond with children leaves lasting genetic protection

Tulane University psychiatrist Dr. Stacy Drury has been given $2.4 million by the National Institutes of Health to test a provocative new theory - how well children bond with a parent in the first year of life leaves lasting genetic protection, poten...

Tute Genomics biomarker discovery platform to support BYU's Alzheimer's disease genetics research

Tute Genomics announced that its genome annotation and discovery platform will support Brigham Young University's (BYU) efforts to advance Alzheimer's disease genetics research.

UPDATE 1-Strong fourth quarter boosts UK engineer Renishaw

July 23 (Reuters) - British engineering company Renishaw Plc reported a 17 percent jump in full-year pretax profit, helped by large orders from a customer in Asia in the fourth quarter and the sale of its stake in industrial design software maker Del...

Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis

NEW YORK, July 23, 2014 /PRNewswire/ -- Dompe, a leader in R&D for new therapeutic solutions for the treatment of rare diseases, announces that rhNGF (Recombinant Human Nerve Growth Factor) has been designated as an orphan drug by the American Food and Drug Administration (FDA). The candidate drug, developed by the research of Dompe, has been designated as an orphan drug for the treatm...

Evolution of a novel organelle in insects

A Toyohashi Tech researcher in cooperation with researchers at RIKEN, Iwate Medical University, Tokyo Institute of Technology, and the National Institute of Genetics, has revealed that aphids synthesize a protein from a gene laterally acquired from b...

Scientists image a beating heart in 3D (w/ Video)

Researchers of the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden report how they managed to capture detailed three-dimensional images of cardiac dynamics in zebrafish. The novel approach: They combine high-speed Selective Pla...

Pelvalon Announces Results from the LIFE Pivotal Trial at the 2014 AUGS/IUGA Conference

SUNNYVALE, Calif., July 23, 2014 /PRNewswire/ -- Pelvalon, Inc. is making its clinical debut at the 2014 AUGS/IUGA Scientific Meeting in Washington, D.C. with the presentation of results from LIFE, a pivotal study of the Pelvalon's Vaginal Bowel Control (VBC) System.  Holly E. Richter, Ph.D, M.D., Director of the Division of Urogynecology and Pelvic Reconstructive Surgery at the University of...

ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome

CALABASAS, Calif., July 23, 2014 /PRNewswire/ -- ArmaGen, a privately held biotechnology company focused on developing revolutionary therapies to treat severe neurological disorders, announced today that it has entered into a worldwide licensing and collaboration agreement with Shire plc to develop AGT-182, an investigational enzyme replacement therapy (ERT) for potential treatment of both th...

OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center

North Carolina’s only public NCI-designated comprehensive cancer center will work with OncLive to educate the oncology community on ongoing cancer prevention, treatment, and research programs. Plainsboro, N.J. (PRWEB) July 23, 2014 OncLive® is pleased to announce that UNC Lineberger Comprehensive Cancer Center has joined its Strategic Alliance Partnership program. By participating in the...

Fastec Imaging Introduces the First High Speed Camcorder

Fastec Imaging has brought the same ease-of-use of today’s digital cameras to the world of high speed imaging. San Diego, California (PRWEB) July 23, 2014 With the ability to record continuously at over 500 frames per second in HD resolution for more than 15 minutes, Fastec Imaging has brought the same ease-of-use of today’s digital cameras to the world of high speed imaging. “Finally, a hi...

Strong pound hits UK engineer Renishaw's annual profit

July 23 (Reuters) - British engineering company Renishaw Plc , under pressure from a strong pound, reported an 11 percent fall in adjusted full-year pretax profit.


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement